m-cenk
Cell therapyexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 21, 2021 (NCT04898543)
Timeline
Indications
Mechanism of action
- Natural killer cellImmunity, passive
Natural killer cell immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06765954 | Phase 2 | Jun 1, 2025 | ImmunityBio, Inc. |
| NCT06765902 | Phase 2 | Jan 31, 2025 | ImmunityBio, Inc. |
| NCT06710288 | Phase 2 | Dec 31, 2024 | ImmunityBio, Inc. |
| NCT04898543 | Phase 1 | Jun 21, 2021 | ImmunityBio, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ImmunityBio, Inc. | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1